The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Pet Pain Management Drugs-Global Market Insights and Sales Trends 2024

Pet Pain Management Drugs-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1843917

No of Pages : 89

Synopsis
The global Pet Pain Management Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pet Pain Management Drugs in various end use industries. The expanding demands from the Dogs, Cats, Horses and Other, are propelling Pet Pain Management Drugs market. NSAIDs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Opioids segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 46%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pet Pain Management Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pet Pain Management Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pet Pain Management Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pet Pain Management Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pet Pain Management Drugs covered in this report include Boehringer Ingelheim, Zoetis, Merck Animal Health, Bayer, Vetoquinol, Norbrook Laboratories, Ceva Sante Animale, Dechra Pharmaceuticals and Chanelle, etc.
The global Pet Pain Management Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boehringer Ingelheim
Zoetis
Merck Animal Health
Bayer
Vetoquinol
Norbrook Laboratories
Ceva Sante Animale
Dechra Pharmaceuticals
Chanelle
Global Pet Pain Management Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pet Pain Management Drugs market, Segment by Type:
NSAIDs
Opioids
Local Anesthetics
Alpha-2 Agonists
Disease-modifying Osteoarthritis Agents
Other Drugs
Global Pet Pain Management Drugs market, by Application
Dogs
Cats
Horses
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pet Pain Management Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Pet Pain Management Drugs
1.1 Pet Pain Management Drugs Market Overview
1.1.1 Pet Pain Management Drugs Product Scope
1.1.2 Pet Pain Management Drugs Market Status and Outlook
1.2 Global Pet Pain Management Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pet Pain Management Drugs Market Size by Region (2018-2029)
1.4 Global Pet Pain Management Drugs Historic Market Size by Region (2018-2023)
1.5 Global Pet Pain Management Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pet Pain Management Drugs Market Size (2018-2029)
1.6.1 North America Pet Pain Management Drugs Market Size (2018-2029)
1.6.2 Europe Pet Pain Management Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Pet Pain Management Drugs Market Size (2018-2029)
1.6.4 Latin America Pet Pain Management Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Pet Pain Management Drugs Market Size (2018-2029)
2 Pet Pain Management Drugs Market by Type
2.1 Introduction
2.1.1 NSAIDs
2.1.2 Opioids
2.1.3 Local Anesthetics
2.1.4 Alpha-2 Agonists
2.1.5 Disease-modifying Osteoarthritis Agents
2.1.6 Other Drugs
2.2 Global Pet Pain Management Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pet Pain Management Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Pet Pain Management Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pet Pain Management Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pet Pain Management Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pet Pain Management Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pet Pain Management Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pet Pain Management Drugs Revenue Breakdown by Type (2018-2029)
3 Pet Pain Management Drugs Market Overview by Application
3.1 Introduction
3.1.1 Dogs
3.1.2 Cats
3.1.3 Horses
3.1.4 Other
3.2 Global Pet Pain Management Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pet Pain Management Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Pet Pain Management Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pet Pain Management Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pet Pain Management Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pet Pain Management Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pet Pain Management Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pet Pain Management Drugs Revenue Breakdown by Application (2018-2029)
4 Pet Pain Management Drugs Competition Analysis by Players
4.1 Global Pet Pain Management Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pet Pain Management Drugs as of 2022)
4.3 Date of Key Players Enter into Pet Pain Management Drugs Market
4.4 Global Top Players Pet Pain Management Drugs Headquarters and Area Served
4.5 Key Players Pet Pain Management Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Pet Pain Management Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Boehringer Ingelheim
5.1.1 Boehringer Ingelheim Profile
5.1.2 Boehringer Ingelheim Main Business
5.1.3 Boehringer Ingelheim Pet Pain Management Drugs Products, Services and Solutions
5.1.4 Boehringer Ingelheim Pet Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Boehringer Ingelheim Recent Developments
5.2 Zoetis
5.2.1 Zoetis Profile
5.2.2 Zoetis Main Business
5.2.3 Zoetis Pet Pain Management Drugs Products, Services and Solutions
5.2.4 Zoetis Pet Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Zoetis Recent Developments
5.3 Merck Animal Health
5.3.1 Merck Animal Health Profile
5.3.2 Merck Animal Health Main Business
5.3.3 Merck Animal Health Pet Pain Management Drugs Products, Services and Solutions
5.3.4 Merck Animal Health Pet Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Pet Pain Management Drugs Products, Services and Solutions
5.4.4 Bayer Pet Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer Recent Developments
5.5 Vetoquinol
5.5.1 Vetoquinol Profile
5.5.2 Vetoquinol Main Business
5.5.3 Vetoquinol Pet Pain Management Drugs Products, Services and Solutions
5.5.4 Vetoquinol Pet Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Vetoquinol Recent Developments
5.6 Norbrook Laboratories
5.6.1 Norbrook Laboratories Profile
5.6.2 Norbrook Laboratories Main Business
5.6.3 Norbrook Laboratories Pet Pain Management Drugs Products, Services and Solutions
5.6.4 Norbrook Laboratories Pet Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Norbrook Laboratories Recent Developments
5.7 Ceva Sante Animale
5.7.1 Ceva Sante Animale Profile
5.7.2 Ceva Sante Animale Main Business
5.7.3 Ceva Sante Animale Pet Pain Management Drugs Products, Services and Solutions
5.7.4 Ceva Sante Animale Pet Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Ceva Sante Animale Recent Developments
5.8 Dechra Pharmaceuticals
5.8.1 Dechra Pharmaceuticals Profile
5.8.2 Dechra Pharmaceuticals Main Business
5.8.3 Dechra Pharmaceuticals Pet Pain Management Drugs Products, Services and Solutions
5.8.4 Dechra Pharmaceuticals Pet Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Dechra Pharmaceuticals Recent Developments
5.9 Chanelle
5.9.1 Chanelle Profile
5.9.2 Chanelle Main Business
5.9.3 Chanelle Pet Pain Management Drugs Products, Services and Solutions
5.9.4 Chanelle Pet Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Chanelle Recent Developments
6 North America
6.1 North America Pet Pain Management Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pet Pain Management Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pet Pain Management Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pet Pain Management Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pet Pain Management Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pet Pain Management Drugs Market Dynamics
11.1 Pet Pain Management Drugs Industry Trends
11.2 Pet Pain Management Drugs Market Drivers
11.3 Pet Pain Management Drugs Market Challenges
11.4 Pet Pain Management Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’